DIRS.INFO The most relevant business & tech news

☆ These Four Common Infections Can Cause Cancer
▼ + stars: | 2024-09-18 | by ( Nina Agrawal | ) www.nytimes.com time to read: +1 min

A majority of cervical cancers, as well as some genital and oral cancers, are caused by a virus. And certain chronic viral infections can lead to liver cancer. Infections like these account for an estimated 13 percent of all cancer cases globally, according to a new report published Wednesday by the American Association for Cancer Research. We are now close to “turning what would have previously been some common cancers into rare diseases,” he said. Human papillomavirusThere are more than 200 types of the HPV virus, including a dozen that significantly increase the risk of cervical, genital and oral cancers.

Persons: Michael Pignone, ” Organizations: American Association for Cancer Research, Duke School of Medicine

☆ Regular aspirin use may help lower risk of colorectal cancer, study finds, especially for those with unhealthy lifestyles
▼ + stars: | 2024-08-01 | by ( Jen Christensen | ) edition.cnn.com time to read: +6 min

CNN —Regular aspirin use may keep the oncologist away, at least when it comes to colorectal cancer, according to a new study, and people with unhealthy lifestyles seemed to see the greatest benefit. Colorectal cancer is the second most common cause of cancer death worldwide, predicted to cause more than 52,500 deaths in the US alone in 2023. The use of two or more regular-strength aspirin or six or more low-dose aspirin per week was considered regular aspirin use for the purpose of this research. Those regular users were found to have an 18% lower risk of developing colorectal cancer than non-users. They argue that doctors should weigh different lifestyle risk factors when they determine whether someone should take regular aspirin to prevent colorectal cancer.

Persons: it’s, Christina Annunziata, ”, Annunziata, Raymond DuBois, Dr, Sanjay Gupta, DuBois, “, Jennifer Davids, shouldn’t, Davids, wasn’t Organizations: CNN, US Preventive Services Task Force, JAMA Oncology, Health, BMI, American Cancer Society, American Association for Cancer Research, CNN Health, Hollings Cancer, Medical University of South, Boston Medical Center Locations: Charleston, Medical University of South Carolina

☆ There’s still no standard test to detect pancreatic cancer early. Scientists are working to change that
▼ + stars: | 2024-04-08 | by ( Jacqueline Howard | ) edition.cnn.com time to read: +11 min

But there is no standard test to detect early cases of pancreatic cancer, before cancer cells have spread and when surgery is more likely to be helpful. But many studies investigating the potential of liquid biopsy tests for the early detection of pancreatic cancer are still in the early phases. The researchers found that their liquid biopsy approach detected 93% of pancreatic cancers among the US volunteers in their study, 91% of pancreatic cancers in the South Korean cohort and 88% of pancreatic cancers in the Chinese cohort. But there is no blood test that can detect early pancreatic cancer. “Smoking is the most important avoidable risk factor for pancreatic cancer,” according to the American Cancer Society.

Persons: ”, Brian Wolpin, ” Wolpin, “ There’s, Ajay Goel, ” Goel, “, Goel, Al Neugut, Columbia University’s Herbert, Dr, Sanjay Gupta, ” Neugut, “ It’s, It’s, Wolpin Organizations: CNN, Dana, Farber Cancer Institute, US Preventive Services Task Force, American Association for Cancer Research, Hope Comprehensive Cancer Center, Molecular Diagnostics, Therapeutics, Surgeons, University of Pennsylvania, UC San Diego, Columbia, Columbia University’s Herbert Irving Comprehensive Cancer Center, Columbia University Mailman School of Public Health, CNN Health, American Cancer Society Locations: United States, City, Japan, South Korea, China, City of Hope, Hope

☆ Moderna shares fall despite promising data from cancer vaccine trial
▼ + stars: | 2023-04-17 | by ( Annika Kim Constantino | ) www.cnbc.com time to read: +2 min

Shares of Moderna fell Monday as Wall Street chewed over new trial results on the personalized cancer vaccine it is developing with Merck . Those results, presented at an American Association for Cancer Research meeting in Florida, add to the initial results on the treatment combination released in December. Analysts from SVB Securities said the results suggest the personalized cancer vaccine shows promise. Wells Fargo analyst Mohit Bansal also said he's expressing "cautious optimism" about the treatment combination. In a Sunday note, Bansal pointed to "trial imbalances" that potentially produced more favorable results for the personalized cancer vaccine.

The Merck/Moderna collaboration is one of several combining powerful drugs that unleash the immune system to target cancers with mRNA vaccine technology. BioNTech SE (22UAy.DE) and Gritstone Bio Inc (GRTS.O) are working on competing cancer vaccines based on mRNA technology. Barr said it took about eight weeks to design a personalized mRNA vaccine for each patient. In the past, similar experimental cancer vaccines were developed targeting a single tumor mutation, or neoantigen. With mRNA technology in combination with Keytruda, "we can create this shotgun approach ... that can create a more potent immune response," Barr said.

The Merck/Moderna collaboration is one of several combining powerful drugs that unleash the immune system to target cancers with mRNA vaccine technology. BioNTech SE (22UAy.DE) and Gritstone Bio Inc (GRTS.O) are working on competing cancer vaccines based on mRNA technology. Barr said it took Moderna about eight weeks to design a personalized mRNA vaccine for each patient. In the past, similar experimental cancer vaccines were developed targeting a single tumor mutation, or neoantigen. With mRNA technology in combination with Keytruda, "we can create this shotgun approach ... that can create a more potent immune response," Barr said.

☆ Cancer death rates continue to fall, driven by new treatments and improved screening
▼ + stars: | 2022-09-21 | by ( Kaitlin Sullivan | Kaitlin Sullivan Is A Contributor For Nbcnews.Com Who Has Worked With Nbc News Investigations. She Reports On Health | Science | ) www.nbcnews.com time to read: +6 min

Significant strides in cancer treatments, diagnostic tools and prevention strategies continue to drive down cancer death rates, according to a report published Wednesday by the American Association for Cancer Research. Death rates from cancer have been falling over the past two decades, particularly sharply in recent years, the group's annual Cancer Progress Report found. “Cancer cells are mavericks, but they are your own cells. Coussens also highlighted developments in cancer drugs that work by targeting specific DNA mutations in cancer cells but noted that more work is still needed. Catching cancer earlyAlso key to cutting cancer death rates is catching the disease as early as possible.

☆ Cancer death rates fall steadily in the US, with more survivors than ever
▼ + stars: | 2022-09-21 | by ( Carma Hassan | ) edition.cnn.com time to read: +5 min

CNN —More people are surviving cancer than ever before in the United States, according to a new report from the American Association for Cancer Research. The report notes that there were only 3 million US cancer survivors in 1971. Declines in smoking and improvements in catching and treating cancer early are driving the change, according to the AACR Cancer Progress Report 2022, released Wednesday. The reversal of Roe v. Wade is also expected to affect cancer care by limiting health care options for pregnant women with cancer, the report said. The Covid-19 pandemic had an effect on cancer in the US, with nearly 10 million breast, colorectal and prostate cancer screenings missed in 2020.

Search resuls for: "American Association for Cancer Research"

8 mentions found